Arrowstreet Capital’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-27,500
| Closed | -$373K | – | 2305 |
|
2020
Q2 | $373K | Buy |
+27,500
| New | +$373K | ﹤0.01% | 2046 |
|
2019
Q2 | – | Sell |
-109,199
| Closed | -$894K | – | 1361 |
|
2019
Q1 | $894K | Buy |
+109,199
| New | +$894K | ﹤0.01% | 1347 |
|
2018
Q2 | – | Sell |
-52,500
| Closed | -$500K | – | 1063 |
|
2018
Q1 | $500K | Buy |
+52,500
| New | +$500K | ﹤0.01% | 958 |
|
2017
Q4 | – | Sell |
-121,089
| Closed | -$2.38M | – | 1226 |
|
2017
Q3 | $2.38M | Buy |
121,089
+82,189
| +211% | +$1.62M | 0.01% | 657 |
|
2017
Q2 | $559K | Buy |
38,900
+24,222
| +165% | +$348K | ﹤0.01% | 863 |
|
2017
Q1 | $135K | Buy |
+14,678
| New | +$135K | ﹤0.01% | 1218 |
|